Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Corium International, Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 4.47||$ 16.2899|
|Low||$ 4.08||$ 3.525|
The current last sale of $4.28 is 21.42% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a commercial stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products that leverage our broad experience in transdermal and transmucosal delivery systems. Together with our partners, we have successfully developed seven marketed products in the prescription drug and consumer markets, and we are the sole commercial supplier of each of those products for our marketing partners. We use our novel transdermal and transmucosal approaches to bring new products to markets that present significant opportunities. Our development platforms enable transdermal delivery of large molecules, or biologics, including vaccines, peptides and proteins, as well as small molecules that are otherwise difficult to deliver in a transdermal dosage form. Our pipeline includes two partnered products that are the subject of applications for approval by the U.S. Food and Drug Administration (the "FDA"). ... More ...
Where does CORI fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-1.52|
|Quarterly EPS Est:||-0.38|